A Phase I Study Of Photodynamic Therapy (PDT) For The Treatment Of Basal Cell Carcinoma (BCC): A Drug/Light Dose Finding Study Utilizing 2-(1-HEXYLOXYETHYL)-2-DEVINYL PYROPHEOPHORBIDE-A (HPPH-PHOTOCLOR).
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs HPPH (Primary)
- Indications Basal cell cancer
- Focus Adverse reactions
- 07 Mar 2011 Biomarkers information updated
- 16 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Sep 2010 Actual end date (Jan 2007) added as reported by ClinicalTrials.gov.